Browse > Article

Biological active components in cigarette mainstream smoke  

Shin, Han-Jae (KT&G Research Institute)
Publication Information
Journal of the Korean Society of Tobacco Science / v.32, no.1, 2010 , pp. 41-54 More about this Journal
Keywords
Citations & Related Records
연도 인용수 순위
  • Reference
1 Van Duuren, B.L., A. Sivak, C. Katz, and S. Melchionne (1971) Cigarette smoke carcinogenesis: Importance of tumor promoters; J. Natl. Cancer Inst. 47: 235-240.
2 Wynder, E. L., Graham, E. A., and Croninger, A. B. (1953) Experimental production of carcinoma with cigarette tar. Cancer Res. 13: 855-864.
3 Hoffmann, D. and E.L. Wynder (1962) A study of air pollution carcinogens. II. The isolation and identification of polynuclear aromatic hydrocarbons from gasoline engine exhaust condensate. Cancer 15: 93-102.   DOI   ScienceOn
4 Homburger, F., A. Treger, and E. Boger (1971) Inhibition of murine subcutane- ous and intravenous benzopentaphene carcinogenesis by sweet orange oils and D-limonene. Oncology 25: 1-10.   DOI   ScienceOn
5 Wynder, E.L. and D. Hoffmann (1961) Biological and chemical studies of tobacco smoke condensate. Proc. Am. Assoc. Cancer Res. 3: 280.
6 Baker, R. R., Massey, E. D. and Smith, G. (2004) An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 42: S53-S83.   DOI   ScienceOn
7 Williams, D., F.J. Wiebel, J.C. Leutz, and H.V. Gelboin. (1971) Effect of polycyclic hydrocarbons in vitro on aryl hydrocarbon (benzo[a]pyrene) hydroxylase. Biochem. Pharmacol. 20: 2130.   DOI   ScienceOn
8 Wynder, E. L., and Graham, E. A. (1950) Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of six hundred and eighty-four proven cases. J. Am. Med. Assoc. 143: 329-336.   DOI
9 Wynder, E. L., Kopf, P, and Ziegler, H. (1957) A study of tobacco carcinogenesis. II. Dose-response studies. Cancer 10: 1193-1200.   DOI   ScienceOn
10 Wynder, E.L. and D. Hoffmann (1959) A study of tobacco carcinogenesis. VII. The role of higher polycyclic hydrocarbons. Cancer 12: 1079-1086.   DOI   ScienceOn
11 Wynder. E.L. and D. Hoffmann (1962) Studies with the gaseous and particulate phase of tobacco smoke. Proc. Am. Assoc. Cancer Res. 3: 373.
12 Wynder, E.L. and D. Hoffmann (1967) Tobacco and tobacco smoke: Studies in experimental carcinogenesis. Academic Press, New York, NY.
13 Thomson, H. V. (1992) International reference method for the smoking of cigarettes. Rec. Adv. Tob. Sci. 18: 69-94
14 Takeda, K., S. Ukawa, and M. Mochizuki (1991) Inhibition by fatty acids of direct mutagenicity of N-nitroso compounds in: Relevance to human cancer of N-nitroso compounds, tobacco and mycotoxins, edited by I.K. O'Neill, J. Chen, and H. Bartsch, IARC, Lyon, France, IARC Sci. Publ. No. 105: 558-563.
15 Teel, R. and A. Castonguay (1992) Antimutagenic effects of polyphenolic compounds. Cancer Lett. 66: 107-113.   DOI   ScienceOn
16 Thompson, H. J (1991) Effect of deficiencies of selenium and vitamin E alone or in combination on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 12: 2175-2179.   DOI   ScienceOn
17 Waddell, W. and C. Marlowe (1983) Inhibition by alcohols of the localization of radioactive nitrosonornicotine in sites of tumor formation. Science 221: 51-52.   DOI
18 Wattenberg, L.W. (1981) Inhibitors of chemical carcinogens; in: Cancer: Achievements, challenges and prospects for the 1980's, edited by J.H. Burchenal, Grune and Stratton, New York, NY, pp. 517-539.
19 Wattenberg, L.W. and J.B. Coccia (1991) Inhibition of 4-methylnitrosam ino-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 12: 115-117.   DOI   ScienceOn
20 Slaga, T.J., L. Jecker, W.M. Bracken, and C.E. Weeks (1979) The effects of weak or non-carcinogenic polycyclic hydrocarbons on 7,12-dimethylbenz- [a]anthracene and benzo [a]pyrene; Cancer Lett. 7: 51-59.   DOI   ScienceOn
21 Stedman, R. L. (1968) The chemical composition of tobacco and tobacco smoke. Chemical Review 68: 153-207.   DOI   ScienceOn
22 Slaga, T.J. and J. DiGiovanni (1984) Inhibition of chemical carcinogenesis; Chapter 21, in: Chemical carcinogens. Second edition, edited by C.E. Searle, American Chemical Society Monograph 182, American Chemical Society, Washington, DC, p. 1279-1321.
23 Steiner, P.E. and H.L. Falk (1951) Summation and inhibition effects of weak and strong carcinogenic hydrocarbons, 1:2-benzanthracene, chrysene, 1:2:5:6-dibenzanthracene, and 20-methylcholanthrene; Cancer Res. 11: 56-63.
24 Stedman, R. L. (1968) The chemical composition of tobacco and tobacco smoke. Chem. Rev. 68: 153-207.   DOI   ScienceOn
25 Rodgman, A. (2001) Studies of polycyclic aromatic hydro-carbons in cigarette mainstream smoke: Identification, tobacco precursors, control of levels: A review. Beitr. Tabakforsch. Int. 19: 361-379.
26 Rodgman, A. and L.C. Cook (1962) The composition of cigarette smoke. XI. Heterocyclic nitrogen compounds from Turkish tobacco smoke. Rec. Adv. Tob. Sci. 6: 176-179.
27 Rodgman, A. (1991) A comparison of the chemical and physical properties of cigarette mainstream smoke (MS), cigarette sidestream smoke (SS), and environmental tobacco smoke (ETS); Document submitted to the Environmental Protection Agency, December, Revised version submitted, June, pp. i-vii + 1-117, see www.rjrtdocs.com 508185686-5809.
28 Rodgman, A. (1994) The chemical composition of environmental tobacco smoke: Some comments on the Occupational Safety and Health Administration's notice on 'Indoor Air Quality' Document submitted to the Occupational Safety and Health Administration, 5 August, pp. i-xiii, 1-172, see www.rjrtdocs.com 515923456-645; 515926645-6833.
29 Schuller, H.M., A. Castonguay, M. Orloff, and G. Rossignol (1991) Modulation of the uptake and metabolism of 4-(N-methylnitrosamino)-1-(3-pyridyl)- 1-butanone by nicotine. Cancer Res. 51: 2009-2114.
30 Slaga, T.J. and R.K. Boutwell (1977) Inhibition of the tumor-initiating ability of the potent carcinogen 7,12-dimethylbenz[a]anthracene by the weak tumor initiator 1,2,3,4-dibenzanthracene; Cancer Res. 37: 129-133.
31 Slaga, T.J., A. Viaje, S.G. Buty, and W.M. Bracken (1978) Dibenz[a,c]- anthracene: A potent inhibitor of skin-tumor initiation by 7,12-dimethyl-benz-[a]anthracene; Res. Comm. Chem. Pathol. Pharmacol. 19: 477-483.
32 Norman, V. (1977) An overview of the vapor phase, semivolatile and nonvolatile components of cigarette smoke. Rec. Adv. Tob. Sci. 3: 8-58.
33 Lee, C.K., C.W. Fulp, D.W. Bombick, and D.J. Doolittle (1996) Inhibition of mutagenicity of N-nitrosamines by tobacco smoke and its constituents. Mutat. Res. 367: 83-92.   DOI   ScienceOn
34 Manabe, S. and Wada, O. (1990) Carcinogenic tryptophan pyrolysis products in cigarette smoke condensate and cigarette smoke-polluted indoor air. Environ. Pollute. 64: 121-132.   DOI   ScienceOn
35 Murphy, S.E. and R. Heilbrun (1990) Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N'-nitrosonornicotine and 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue. Carcinogenesis 11: 1663-1666.   DOI   ScienceOn
36 Phillips, D. H. (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23: 1979-2004.   DOI   ScienceOn
37 Ramel, C., U.K. Alekperov, B.N. Ames, T. Kada, and L.W. Wattenberg (1986) Inhibitors of mutagenesis and their relevance to carcinogenesis; Report by ICPEMC Expert Group on Antimutagens and Desmutagens; Mutat. Res. 168: 47-65.   DOI   ScienceOn
38 Roberts, D. L. Natural tobacco flavor (1988) Recent Adv. Tob. Sci. 14, 49-81.
39 Rodgman, A. The analysis of cigarette smoke condensate. II. The pretreatment of Camel blend tobacco; RDR, (1956) No. 12, November 1, see www.rjrtdocs.com 501008294-8336
40 Rodgman, A. The analysis of cigarette smoke condensate. III. Flue-cured tobacco; RDR, 1957, No. 4, March 14, see www.rjrtdocs.com 501008337-8377.
41 Rodgman, A. and L.C. Cook (1960) The composition of cigarette smoke. IV. $\alpha$-Tocopherol. Rec. Adv. Tob. Sci. 4: 7-8.
42 Izard, C., J. LaCharpagne, and P. Testa (1966) Sur l'activite biologique de divers condensats de fumee de cigarettes, revelee par les tests auxiniques [On the biological activity disclosed in cellular tests of different cigarette smoke condensates]; Compt. Rend. 262D: 1859-1861.
43 Homburger, F. and A. Treger (1965) Effects of intravenous carcinogen and tobacco condensate injections upon the incidence of lung tumors in A/He mice; in: Lung tumors in animals, edited by L. Severi, Division of Cancer Research, University of Perugia, Italy, pp. 527-536.
44 International Agency for Research on Cancer (IARC) (1985) Chemistry and analysis of tobacco smoke. In: IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Volume 38, Tobacco Smoking pp. 83-126. IARC, Lyon.
45 Ishiguro, S., and Sugawara, S. (1986) The Chemistry of Tobacco Smoke (in Japanese) Central Institute, Japanese Tobacco Monopoly Corporation, Yokahama, Japan, p. 202 (English translation (1981), p. 247).
46 Johnstone, R. A. W. and Plimmer, J. R. (1959) The chemical constituents of tobacco and tobacco smoke. Chemical Review 59: 885-936.   DOI
47 Keith, C.H. and Tesh, P.G. (1965) Measurement of the total smoke issuing from a burning cigarette. Tob. Sci. 9: 61-64.
48 Lee, C.K. and E.A. Reed (1983) Ames test on smoke condensates: A summary; RJRT R&DM, No. 20, May 9, see www.rjrtdocs.com 508352301-2303.
49 Eatough, D.J., L.D. Hansen, and E.A. Lewis (1989) The chemical characteriza- tion of environmental tobacco smoke; in: Environmental tobacco smoke, edited by D.J. Ecobichon and J.M. Wu, Proc. International Symposium at McGill University, PQ, Canada, Lexington Books, D.C. Heath and Company, Lexington, MA, 1990, p. 3-39.
50 Lee, C.K., J.A. Munoz, C.W. Fulp, K.M. Chang, J. Rogers, M.F. Borgerding, and D.J. Doolittle (1993) Inhibitory activity of cigarette-smoke condensate on the mutagenicity of heterocyclic amines. Mutat. Res. 322: 21-32.
51 Falk, H.L., P. Kotin, and S. Thompson (1964) Inhibition of carcinogenesis. The effect of hydrocarbons and related compounds. Arch. Environ. Hlth. 9: 169-179.   DOI   ScienceOn
52 Fay, J.R., L.R. Perry, L.A. Kanerva, C.C. Sigman, and C.T. Helmes (1984). Inhibitors of chemical carcinogenesis; Document prepared in 1984, revised in 1985 for Sci. Coordinator Environ. Cancer, National Cancer Institute, Bethesda, MD, 1985, p. 1-96.
53 Green, C.R. (1977a) Some relationships between tobacco leaf and smoke composition. In: Proc. 173rd Am. Chem. Soc. Symp., Rec. Adv. Chem. Comp. Tob. Tob. Smoke. p. 426-70.
54 Green, C.R. (1977b) Neutral oxygenated compounds in cigarette smoke and their possible precursors. Rec. Adv. Tob. Sci. 3: 94-120.
55 Green, C. R. and Rodgman, A. (1996) The tobacco chemists research conference: a half century forum for advances in analytical methodology of tobacco and its products. Rec. Adv. Tob. Sco. 22: 131-304.
56 Hecht, S.S., Schmeltz, I. and Hoffmann, D. (1977) Nitrogenous compounds in cigarette smoke and their possible precursors. Rec. Adv. Tob. Sci. 3: 59-93.
57 Curvall, M., Enzell, C. R. and Pettersson, B. (1984) An evaluation of the utility of four in vitro short term tests for predicting the cytotoxicity of individual compounds derived from tobacco smoke. Cell Biol. Toxicol. 1: 173-193.   DOI   ScienceOn
58 Hoffman, H.E. and A.C. Griffin (1958) Action of cigarette tar and smoke on chemically induced carcinogenesis. Texas Rep. Biol. Med. 16: 333-345.
59 Crabtree, H.G. (1945) Influence of unsaturated di- basic acids on the induction of skin tumors by chemical carcinogens. Cancer Res. 5: 346-351.
60 Crabtree, H.G. (1946) Some effects of aromatic hydrocarbons on sulfur metabolism and tumor induction in mice. Cancer Res. 6: 553-559.
61 DiGiovanni, J., T.J. Slaga, D.L. Berry, and M.R. Juchau (1980) Inhibitory effects of environmental chemicals on polycyclic aromatic hydrocarbon carcinogenesis; in: Carcinogenesis. A comprehensive survey. Vol. 5, edited by T.J. Slaga, Raven Press, New York, NY, p. 145-168.
62 Dipple, A., R.C. Moschel, and C.A.H. Bigger (1984) Polynuclear hydrocarbons; Chapter 2, in: Chemical carcinogens. Second edition, edited by C.E. Searle, American Chemical Society Monograph 182, American Chemical Society, Washington, DC, p. 41-163.
63 Cohen, G.M., W.P. Bracken, R.P. Iyer, D.L. Berry, and T.J. Slaga (1979) Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-$\rho$-dioxin on benzo-[a]pyrene and 7,12-dimethylbenz[a] anthracene tumor initiation and its relationship to DNA binding. Cancer Res. 39: 4027-4033.
64 Doll, R., and Hill, A. B. (1950) Smoking and carcinoma of the lung: Preliminary report. Br. Med. J. II, 739-748.
65 Dontenwill, W., Chevalier, H. J., Harke, H.-P., Lafrenz, U., Reckzeh, G., and Schneider, B. (1973) Investigation of the effects of chronic cigarette smoke inhalation in Syrian golden hamsters. J. Natl. Cancer Inst. 51: 1781-1832.   DOI
66 Chung, F.L., M.A. Morse, K.I. Eklind, and Y. Xu (1993) Inhibition of tobacco specific nitrosamine induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea; in: Tobacco smoking and nutrition: Influence of nutrition on tobacco-associated health risks, edited by J.N. Diana and W.A. Pryor, Ann. NY Acad. Sci. 686: 186-202.   DOI
67 Cooper, R. L., Lindsey, A. J. and Wallwe, R. E. (1954) The presence of 3,4-benzopyrene in cigarette smoke. Chem. Ind. 46: 14-18.   DOI
68 Chung, F.L., A. Juchatz, J. Vitarius, and S.S. Hecht (1984) Effects of dietary compounds on $\alpha$-hydroxylation of N-nitrosopyrrolidine and N'-nitroso-nornicotine in rat target tissues. Cancer Res. 44: 2924-2928.
69 Crabtree, H.G. (1944) Influence of bromobenzene on the induction of skin tumors by 3,4-benzopyrene. Cancer Res. 4: 688-693.
70 Brown, B., J.T. Avalos, C.K. Lee, and D.J. Doolittle (2001) The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitros-amino)-1-(3-pyridyl)-1-butanol (NNAL); 55th Tobacco Science Research Conference, Program Booklet and Abstracts, Vol. 55, Paper No. 10, p. 26.
71 Chung, F.L., A. Juchatz, J. Vitarius, B. Reiss, and S.S. (1984) Hecht: Inhibition of target tissue activation of N'-nitrosonornicotine and N-nitroso-pyrrolidine by dietary components; in: N-Nitroso compounds: Occurrence, biological effects and relevance to human cancer, edited by I.K. O'Neill, R.C. von Borstel, C.T. Miller, J. Long, and H. Bartsch, IARC, Lyon, France, IARC Sci. Publ. No. 57: 797-804.